This Alumis Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday

BenzingaOct 31 11:37 ET

Enliven Therapeutics Price Target Announced at $36.00/Share by Jones Trading

Dow JonesOct 31 07:22 ET · Ratings

JonesTrading Initiates Enliven Therapeutics(ELVN.US) With Buy Rating, Announces Target Price $36

Moomoo NewsOct 30 16:31 ET · Ratings

H.C. Wainwright Maintains Enliven Therapeutics(ELVN.US) With Buy Rating, Maintains Target Price $37

Moomoo NewsOct 1 09:31 ET · Ratings

Enliven Therapeutics Garners Buy Rating on Robust Clinical Results and Safety Profile for Lead CML Drug Candidate

TipRanksOct 1 08:35 ET · Ratings

TD Cowen Maintains Enliven Therapeutics(ELVN.US) With Buy Rating

Moomoo NewsSep 30 07:33 ET · Ratings